Patients and doctors are being misled by published data on medicines

Published October 13, 2010

Patients and doctors are being misled by published data on medicines
The drug reboxetine is, overall, an ineffective and potentially harmful antidepressant, according to a comprehensive study of the evidence published on bmj.com today.
Read more on EurekAlert!

First phase II trial of heart disease treatment for Duchenne muscular dystrophy launched
( Kennedy Krieger Institute ) Kennedy Krieger announced the launch of a first-of-its-kind phase II clinical trial to investigate a treatment for heart disease in Duchenne muscular dystrophy (DMD). Made possible by a $ 545,000 grant from Pilot Trials Now, a DMD initiative of Charley’s Fund Inc. and the Nash Avery Foundation, with additional support from Pfizer Inc., the study will examine whether …
Read more on EurekAlert!

New Institute Paves Way for Rapid Cancer Drug Development
GREENVILLE, S.C., Oct. 12 /PRNewswire-USNewswire/ — Greenville Hospital System University Medical Center (GHS) unveiled details of its new Institute for Translational Oncology Research, a visionary cancer initiative that will help pave the way for new breakthroughs in rapid drug development, diagnostic discovery and advanced cancer care. ITOR is part of the GHS Cancer Center, a recognized …
Read more on redOrbit